1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Human Papillomavirus (HPV) Prophylaxis Landscape, 2017

Human Papillomavirus (HPV) Prophylaxis Landscape, 2017

  • July 2017
  • 79 pages
  • ID: 4985931


Table of Contents

DelveInsight’s ‘Human PapillomaVirus (HPV) Prophylaxis Landscape, 2017’ Report provides an overview of the Human PapillomaVirus (HPV) and market trends of the Human PapillomaVirus (HPV) Vaccines in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and Rest of World (RoW).
The Report also provides in-depth analysis on the HPV Vaccines covering pre-clinical and clinical studies and Collaborations details. The Report provides the HPV vaccines licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. The Report provides a comprehensive review of the market trends, key company profiles including its business and product developments.

The HPV vaccines have been introduced in US and most EU/EEA countries. As of May 2012, the vaccination advisory bodies in 22 of 29 countries has made a recommendation in favor of HPV vaccination, compared to 12 out of 27 countries in February 2008 in Europe. According to DelveInsight, a total of 7,288,315 people were vaccinated with HPV Vaccines in 2016 and the total number of vaccinated people with HPV Vaccine is expected to reach XXXX in 2025.

According to DelveInsight, the Total Market Size of Human PapillomaVirus (HPV) Vaccines including 6MM (the United States and EU5 countries) and RoW was estimated to be USD 1.98 Billion in 2016. The market is expected to reach a total of USD XXXX Millions by 2025 with a CAGR OF XXX% for the period 2015-2025.

Market size has increased in recent years for HPV due to the approval of Gardasil 9 (Merck & Co.) which targets 9 different HPV types (Types 16, 18, 31, 33, 45, 52, and 58). Although the overall HPV Vaccines market is increasing, the sales of Cervarix (GlaxoSmithKline) has been declining over the years owing to the company’s decision to stop the vaccines’ supply in the United States. GlaxoSmithKline has taken this step due to the low market demand of Cervarix in the US.

Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Human PapillomaVirus (HPV) Vaccines market.
• Organize sales and marketing efforts by identifying the best opportunities for Human PapillomaVirus (HPV) Vaccines in US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
• To understand the future market competition in the global Human PapillomaVirus (HPV) Vaccines market and Insightful review of the key market drivers and barriers.
• To understand the regulatory scenario in major markets.
• Overview of the global HPV Vaccines pipeline scenario, products and associated companies information.

• Coverage of global HPV Vaccines under development.
• Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities.

• The Report also covers the detailed global historical and forecasted Human PapillomaVirus (HPV) Vaccines market covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Vaccines Industry: Forecasts to 2025

  • $ 5795
  • Industry report
  • March 2018
  • by Transparency Market Research

Vaccines Market: OverviewVaccines help in stimulating the body’s immune system in order to produce antibodies which aid in protecting the body against infectious diseases.The administration of vaccines ...

Bladder Cancer: Dynamic Market Forecast to 2026

Bladder Cancer: Dynamic Market Forecast to 2026

  • $ 8495
  • Industry report
  • March 2018
  • by GlobalData

Bladder Cancer: Dynamic Market Forecast to 2026SummaryBladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is ...

World Vaccine Markets to 2022

World Vaccine Markets to 2022

  • $ 25656
  • Industry report
  • March 2018
  • by Global Research & Data Services

The report package World Vaccine Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in the world.Along with a global vaccines market ...

The Global Influenza Market $ 4950 April 2018

Download Unlimited Documents from Trusted Public Sources

Vaccine Market and Influenza Statistics in India and the US

  • June 2018
    6 pages
  • Vaccine  



  • United States  


View report >

Vaccine Market in India

  • June 2018
    15 pages
  • Vaccine  

    Infectious Dise...  

  • India  


View report >

Infectious Disease Statistics in the US

  • June 2018
    10 pages
  • Infectious Dise...  



  • United States  

    North America  

View report >

Related Market Segments :


Sexually Transmitted Disease


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on